You are here

Stinchcombe, Thomas Eldridge

Positions:

Professor of Medicine

Medicine, Medical Oncology
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Education:

M.D. 1995

M.D. — University of Virginia School of Medicine

Internal Medicine Residency

University of Michigan at Ann Arbor

Hematology/Oncology Fellowship

University of North Carolina at Chapel Hill School of Medicine

Grants:

BLU-667

Administered By
Duke Cancer Institute
AwardedBy
Blueprint Medicines Corporation
Role
Principal Investigator
Start Date
October 03, 2017
End Date
September 30, 2022

ATOMIC

Administered By
Duke Cancer Institute
AwardedBy
Ariad Pharmaceuticals
Role
Principal Investigator
Start Date
February 15, 2017
End Date
September 08, 2022

MK-3475-604-00

Administered By
Duke Cancer Institute
AwardedBy
Merck
Role
Principal Investigator
Start Date
March 24, 2017
End Date
June 30, 2022

B7461006

Administered By
Duke Cancer Institute
AwardedBy
Pfizer, Inc.
Role
Principal Investigator
Start Date
August 07, 2017
End Date
May 31, 2022

AFT - 17

Administered By
Duke Cancer Institute
AwardedBy
Alliance Foundation Trials, LLC
Role
Principal Investigator
Start Date
July 25, 2017
End Date
February 28, 2022

BMS209-722:CheckMate

Administered By
Duke Cancer Institute
AwardedBy
The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership
Role
Principal Investigator
Start Date
November 01, 2016
End Date
October 31, 2021
Show More